gilead sciences
-
FDA approves first coronavirus drug, may help recoveryThe drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.WorldOct 22, 2020
![]()
-
Remdesivir cut coronavirus recovery time by 5 days, company’s final study suggestsThe antiviral drug, which was recently used to treat U.S. President Donald Trump, also appeared to reduce the risk of death in some patients.HealthOct 8, 2020
![]()
-
U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatmentThe Department of Health and Human Services has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead for American hospitals through September.HealthJun 30, 2020
![]()
-
Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.The amount that patients pay out of pocket depends on insurance, income and other factors.WorldJun 29, 2020
![]()
-
Coronavirus: Drug trial sees ‘encouraging’ results but researchers say more study neededNearly 70 per cent of patients tested in the U.S., Europe, Canada and Japan improved after taking the Gilead Sciences drug remdesivir, but eight of the patients worsened while seven died.HealthApr 10, 2020
![]()
